Ver mas grande
SETDB2 antibody
FT-FNab07772
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB |
| Target | SETDB2 |
| Research Area | Epigenetics, Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | SET domain, bifurcated 2 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Histone-lysine N-methyltransferase SETDB2|Chronic lymphocytic leukemia deletion region gene 8 protein|Lysine N-methyltransferase 1F|SET domain bifurcated 2|SETDB2|C13orf4|CLLD8|KMT1F |
| Host | Rabbit |
| UniProt ID | Q96T68 |
| Gene ID | 83852 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human |
| Observed MW | 101 kDa |
| Background | Histone methyltransferase involved in left-right axis specification in early development and mitosis. Specifically trimethylates 'Lys-9' of histone H3(H3K9me3). H3K9me3 is a specific tag for epigenetic transcriptional repression that recruits HP1(CBX1, CB |
Más información
SETDB2 antibody